According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Private equity giant KKR (KKR) has upped its offer price for Japan-based IT company Fuji Soft in its ongoing complex takeover ...

TOKYO (Reuters) - U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share ...

U.S. private equity firm KKR will raise its offer price for Japanese IT company Fuji Soft by more than 4 per cent to take it ...

U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share from 9,451 yen, ...

Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

U.S. private equity firm KKR will raise its tender offer price for Japanese IT company Fuji Soft to 9,850 yen a share from ...

Here's a look at the top healthcare deals this week. Bain Capital Private Equity proposed to buy the remaining shares of Surgery Partners, an ambulatory surgery center provider in which the ...